Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2020
Home
2020
April 7, 2020
Published by
Tiffany McMillan
on
April 7, 2020
Categories
Cellmid share placement raises $6 million
April 7, 2020
Published by
Tiffany McMillan
on
April 7, 2020
Categories
Total number of +securities proposed to be issued for a placement or other type of issue
April 6, 2020
Published by
Tiffany McMillan
on
April 6, 2020
Categories
Cellmid Limited (ASX: CDY) – Suspension from Official Quotation
April 2, 2020
Published by
Tiffany McMillan
on
April 2, 2020
Categories
Cellmid Limited (ASX: CDY) – Trading Halt
March 29, 2020
Published by
Dominic Burg
on
March 29, 2020
Categories
Market Update on COVID-19
March 29, 2020
Published by
Dominic Burg
on
March 29, 2020
Categories
Reinstatement to Official Quotation
March 29, 2020
Published by
Dominic Burg
on
March 29, 2020
Categories
Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
March 6, 2020
Published by
Tiffany McMillan
on
March 6, 2020
Categories
1H FY2020 Financial Results
March 6, 2020
Published by
Tiffany McMillan
on
March 6, 2020
Categories
New Distribution channels to drive revenue growth from 2H FY2020
Prev page
1
2
3
4
5
6
7
8
9
Next page
